Halaman 3 - Kemoterapi leukemia Dokter Terbaik - TOP-97 dokter

Dr. Alemdar berspesialisasi dalam kemoterapi leukemia dengan pelatihan ekstensif di Rumah Sakit Universitas Akdeniz, pusat onkologi terkemuka.

• Bersertifikat dewan dalam onkologi medis dengan pengalaman lebih dari 15 tahun
• Bekerja di beberapa rumah sakit bergengsi termasuk Rumah Sakit Universitas Akdeniz
• Berspesialisasi dalam penyakit dalam sebelum berfokus pada onkologi

Dr. Eckhart Weidmann memimpin sektor Hematologi di Klinik Nordwest, berspesialisasi dalam pengobatan kelainan darah dengan pengalaman praktik lebih dari 30 tahun.

• Salah satu dokter terbaik untuk limfoma non-Hodgkin
• Profesor dengan keahlian akademis dan klinis yang luas
• Fokus pada leukemia dan kelainan darah lainnya

Prof. Myriam Ben Arush, seorang spesialis Onkologi Pediatrik yang diakui secara internasional, memimpin Divisi Pediatrik di Rumah Sakit Anak Ruth Rappaport.

• Penerima Penghargaan Kementerian Kesehatan atas karya yang luar biasa
• Dianugerahi gelar Chevalier de la Legion d'Honneur di Prancis
• Diakui sebagai salah satu dokter paling peduli di dunia oleh Asosiasi Medis Dunia
• Anggota kelompok onkologi anak di Amerika Serikat dan beberapa perkumpulan kanker Eropa

Spesialis radioterapi yang berfokus pada kemoterapi leukemia – Dr. Drumea membawa keahlian yang ditargetkan ke Pusat Medis Rambam.

• Dokter Onkologi dengan fokus pada pengobatan kanker yang presisi
• Menggunakan teknik radioterapi canggih
• Bekerja di Pusat Medis Rambam – rumah sakit terkemuka di Israel

Kepala Hematologi di Pusat Medis Hadassah – Profesor Ben-Yehuda berspesialisasi dalam diagnostik molekuler dan terapi gen untuk kanker darah.

• Pelatihan di Memorial Sloan-Kettering Cancer Center di New York
• Wanita pertama yang memimpin Fakultas Kedokteran Hadassah
• Penerima Penghargaan "Healing with the Heart Award" atas perawatan pasien yang luar biasa
• Anggota International Society of Hematology and Hemato-Oncology

Spesialis terkemuka Israel dalam imunoterapi kanker paru-paru – Prof. Peled mengepalai Unit Kanker Toraks di Pusat Kanker Davidoff.

• Ahli dalam pengobatan personalisasi dan imunoonkologi
• Penerima penghargaan MERIT ASCO untuk penelitian kanker paru-paru
• Ketua Komite Deteksi Dini & Pencegahan IASLC
• Menjalani pelatihan Fellowship di University of Colorado Denver

Sebagai Kepala Institut Onkologi sejak 1994, Tamar Jablonski-Perec membawa pengalaman kepemimpinan puluhan tahun untuk kemoterapi leukemia di Hadassah Medical Center.

• Profesor Onkologi di Hebrew University sejak 2006
• Menyelesaikan program fellowship onkologi di Sloan-Kettering Cancer Center
• Menerima beasiswa keunggulan dari Hadassah Medical School
• Anggota dari berbagai komunitas penelitian kanker internasional

Dr. Spielberg berspesialisasi dalam kemoterapi leukemia di Assuta Medical Center.

• Onkohematolog dengan fokus pada kanker darah
• Bekerja di salah satu pusat medis terkemuka di Israel
• Menyediakan rencana perawatan yang dipersonalisasi untuk pasien leukemia

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Berspesialisasi dalam onkologi dan radiologi di Pusat Medis Assuta.

• Berpengalaman dalam protokol kemoterapi leukemia
• Menggabungkan keahlian onkologi dan radiologi
• Berpraktik di pusat medis terkemuka

Kepala Dokter Pusat Onkologi di Assuta Medical Center – pemimpin dalam perawatan kanker dengan fokus pada pengobatan leukemia.

• Dokter onkologi yang berspesialisasi dalam protokol kemoterapi
• Menangani kasus leukemia kompleks di pusat medis tingkat atas
• Memimpin program perawatan Pusat Onkologi

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Kim berspesialisasi dalam onkologi dan ginekologi, menawarkan perawatan ahli di Samsung Medical Center.

• Berfokus pada pengobatan onkoginekologis
• Bekerja di fasilitas medis tingkat atas
• Menyediakan perawatan khusus untuk kasus-kasus kompleks